Pfizer scientists developing the COVID-19 vaccine in two laboratories located near the pandemic's initial epicenter in the U.S.
Image Source: 
EYEPRESS/via Reuters Connect
Featured

Chad P. Bown (PIIE)

The United States made hundreds of millions of doses of safe and effective COVID-19 vaccines available by early 2021, a success largely credited to the public-private partnership known as Operation Warp Speed. But US vaccine production stopped growing in mid-2021, while EU production surged ahead. New research indicates that use of the Defense Production Act (DPA) of 1950 to contract with vaccine manufacturers may have been partly to blame for lagging US production.

The Peterson Institute for International Economics building is open on a limited basis. Employees and visitors must be fully vaccinated, with a booster shot, and verify vaccination records before entering the building by registering with CrowdPass, a HIPAA-compliant web application service.

Photo Credit: 
EYEPRESS/via Reuters Connect

Highlighted PIIE Topics